Curis to Present Updated Data from the TakeAim Leukemia Study

Go back to Curis to Present Updated Data from the TakeAim Leukemia Study
Curis, Inc. (NASDAQ: CRIS) Delayed: 4.69 -0.2 (4.09%)
Previous Close $4.89    52 Week High $3.70 
Open $5.21    52 Week Low $1.25 
Day High $5.30    P/E N/A 
Day Low $4.60    EPS $-0.15 
Volume 137,213